1-6 of 6
Boris Bienvenu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

Clinical Trials & Observations
Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster, Thomas Barba, Mathieu Gerfaud-Valentin, Arsène Mékinian, Henrique Coelho, Gaelle Fossard, Fiorenza Barraco, Lionel Galicier, Boris Bienvenu, Pierre Hirsch, Guillaume Vial, Anne Blandine Boutin, Joris Galland, Guillaume Le Guenno, Adrien Bigot, Kenneth J. Warrington, Tanaz A. Kermani, Peter C. Grayson, Bhavisha A. Patel, David B. Beck, Yvan Jamilloux, Pierre Fenaux, Pierre Sujobert
Journal: Blood
Blood (2022) 140 (8): 927–931.
https://doi.org/10.1182/blood.2022016642
Published: 2022
Includes: Supplemental data
Journal Articles

Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective Study

Maël Heiblig, Marcela A Ferrada, Mathieu Gerfaud-Valentin, Thomas Barba, Arsène Mékinian, Matthew Koster, Henrique Coelho, Gaelle Fossard, Fiorenza Barraco, Lionel Galicier, Boris Bienvenu, Pierre Hirsch, Guillaume Vial, Anne Blandine Boutin, Guillaume Le guenno, Adrien Bigot, Kenneth Warrington, Tanaz Kermani, Yvan Jamilloux, Peter C Grayson, Bhavisha A. Patel, David B. Beck, Pierre Fenaux, Pierre Sujobert
Journal: Blood
Blood (2021) 138 (Supplement 1): 2608.
https://doi.org/10.1182/blood-2021-150394
Published: 2021
Journal Articles

Vasculitis Associated with Large Granular Lymphocytes Leukemia

Alexandra Audemard, MD student, Thierry Lamy, MD, PhD, Benoit Bareau, MD, Felipe Suarez, MD, PhD, Margaret Macro, MD, Loic Guillevin, MD, PhD, Flore Sicre, MD, Florence Truquet, Salaun Veronique, Jerome Rey, MD, Estibaliz Lazzaro, MD, PhD, Jonathan Boutemy, MD, Laurence Verneuil, MD, PhD, Stephane Cheze, Nicolas Schleinitz, MD, PhD, Thierry Lobbedez, MD, Loic Geffray, MD, Cindy Castrale, MD, Boris Bienvenu, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 5109.
https://doi.org/10.1182/blood.V120.21.5109.5109
Published: 2012
Journal Articles

Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease

Clinical Trials & Observations
Achille Aouba, Sophie Georgin-Lavialle, Christian Pagnoux, Nicolas Martin Silva, Amédée Renand, Françoise Galateau-Salle, Sophie Le Toquin, Henri Bensadoun, Frederique Larousserie, Stéphane Silvera, Nicole Provost, Sophie Candon, Raphaèle Seror, Mathilde de Menthon, Olivier Hermine, Loïc Guillevin, Boris Bienvenu
Journal: Blood
Blood (2010) 116 (20): 4070–4076.
https://doi.org/10.1182/blood-2010-04-279240
Published: 2010
Journal Articles

Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development

Armelle Le Campion, Marie-Claude Gagnerault, Cédric Auffray, Chantal Bécourt, Maud Poitrasson-Rivière, Eliette Lallemand, Boris Bienvenu, Bruno Martin, Françoise Lepault, Bruno Lucas
Journal: Blood
Blood (2009) 114 (9): 1784–1793.
https://doi.org/10.1182/blood-2008-12-192120
Published: 2009
Includes: Supplemental data
Journal Articles

Self-recognition is crucial for maintaining the peripheral CD4 + T-cell pool in a nonlymphopenic environment

Bruno Martin, Chantal Bécourt, Boris Bienvenu, Bruno Lucas
Journal: Blood
Blood (2006) 108 (1): 270–277.
https://doi.org/10.1182/blood-2006-01-0017
Published: 2006